New drug shows promise for severe eczema in major trial
Disease control
Completed
This study tested whether a new drug called SIM0718 is effective and safe for treating moderate to severe atopic dermatitis (eczema). It involved 259 teenagers and adults whose eczema was not well-controlled with standard creams. Participants were randomly assigned to receive eit…
Phase: PHASE3 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Apr 02, 2026 05:12 UTC